0000899243-19-009894.txt : 20190403
0000899243-19-009894.hdr.sgml : 20190403
20190403202210
ACCESSION NUMBER: 0000899243-19-009894
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190402
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sigal Nolan Howard
CENTRAL INDEX KEY: 0001323291
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 19730906
MAIL ADDRESS:
STREET 1: 941 BERRY AVENUE
CITY: LOS ALTOS
STATE: CA
ZIP: 94024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-02
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001323291
Sigal Nolan Howard
C/O AILERON THERAPEUTICS, INC.
490 ARSENAL WAY
WATERTOWN
MA
02472
1
0
0
0
Stock Option (right to buy)
1.82
2019-04-02
4
A
0
20000
0.00
A
2029-04-01
Common Stock
20000
20000
D
This option was granted on April 2, 2019. The shares underlying the option are scheduled to vest in equal annual installments over three years from April 2, 2019.
/s/ Nolan Howard Sigal
2019-04-03